Quality Responsibility Sample Clauses

The Quality Responsibility clause assigns accountability to one or more parties for ensuring that goods or services meet specified standards. Typically, this clause outlines the required quality benchmarks, the methods for inspection or testing, and the procedures to address any deficiencies, such as repair, replacement, or rejection of non-conforming items. Its core function is to clearly define who is responsible for quality assurance, thereby minimizing disputes and ensuring that deliverables meet the agreed-upon expectations.
Quality Responsibility. The Parties acknowledge that, in order to meet regulatory requirements prior to the commencement of any supply of Antibody Raw Material or Antibody Product in Finished Form, appropriate quality assurance agreements relating to such supply must be entered into between the Parties and between each Party and its Third Party manufacturers. The Parties will negotiate such quality assurance agreements in good faith having regard to the document entitled “Quality Responsibilities” and dated March 12, 2002. If the Parties are unable to conclude any such agreement then the matter shall be referred at the request of either Party to the Collaboration Committee.
Quality Responsibility. Assure that all activities associated with the manufacture of Drug Substance are performed in compliance with cGMP. X Review necessary Batch documentation, approve and disposition Drug Substance. X
Quality Responsibility. CBSB is responsible for meeting cGMP compliance in the manufacture of Drug Substance for Tercica, including without limitation, documentation of all completed Batch Records and quality control testing, calibration and validation of Equipment, the CBSB Facility and utilities, acceptable environmental monitoring results, and acceptable resolution of Deviations and ICARs. Tercica is responsible for the final review, approval and release of the Drug Substance and retains full responsibility for the disposition and release of the Drug Substance for any purpose. Any dispute between Tercica and CBSB with regard to failure or non-conformance of the Drug Substance shall be subject to the procedures as set forth in the MSA. Tercica’s disposition and release will be independent of CBSB’s Quality Review and Approval.
Quality Responsibility. 4.2.1 According to the agreement in Clause 1.1 above, if the product has quality problems, the buyer has the right to require the seller to immediately correct or immediately deliver the substitute product. 4.2.2 If the product with quality problems has the risk of affecting the production or delivery of the buyer, the buyer has the right to carry out necessary repair or replacement without the consent of the seller. 4.2.3 The seller shall compensate the buyer for the direct and indirect losses arising from the delivery of products with quality problems, including but not limited to the expenses for assembly and disassembly, testing and analysis, destruction and transportation. 4.2.4 If the buyer decides to recall or correct the sold complete machine due to the serious quality problems of the seller’s products, the Seller shall compensate the buyer for the expenses related to the recall or batch rectification.
Quality Responsibility. Irrespective of an inspection bythe organisation, the manufacturer's responsibility lies with the supplier for a design that conforms to the order and complies with the respective regulations. The supplier undertakes to align his QM system with the zero-defect strategy and to take all necessary measures for quality assurance. If the supplier detects quality defects, he shall inform the organization thereof and of any remedial measures envisaged immediately in writing. The organization must be protected against damage (delivery of defective components, wrong deliveries, short deliveries, etc.)
Quality Responsibility. The Contractor responsibilities include but are not limited to the following:
Quality Responsibility. Supplier shall provide appropriate technical personnel to meet with the HP' Engineering team not less than once a week, for the duration necessary to review all quality issues identified by HP GSO. HP GSO reserves the right to request additional meetings as required to address quality/reliability issues.